Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, Nomura Holdings, Inc. (NMR) has a Wall Street consensus price target of $5.79, based on estimates from 9 covering analysts. With the stock currently trading at $9.00, this represents a potential downside of -35.7%. The company has a market capitalization of $26.61B.
Analyst price targets range from a low of $5.79 to a high of $5.79, representing a 0% spread in expectations. The median target of $5.79 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, NMR trades at a trailing P/E of 12.7x and forward P/E of 11.3x. The forward PEG ratio of 1.04 indicates reasonable valuation for growth. Analysts expect EPS to grow -99.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $1435.20, with bear and bull scenarios of $-93.17 and $3474.08 respectively. Model confidence stands at 34/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how NMR stacks up against sector leader JPMorgan Chase & Co..
Start ComparisonNMR's consensus price target is $5.79, -35.7% below the current price of $9. The 9 analysts tracking NMR see downside risk at present valuations.
NMR has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 7 Hold ratings making up the largest segment. The consensus 12-month price target of $5.79 implies -35.7% downside from current levels.
With a forward P/E of 11.3464x, NMR trades at a relatively low valuation. The consensus target of $5.79 implies -35.7% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $5.79 for NMR, while the most conservative target is $5.79. The consensus of $5.79 represents the median expectation. Our quantitative valuation model projects a bull case target of $3474 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NMR is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 7 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NMR stock forecast based on 9 Wall Street analysts shows a consensus price target of $5.79, with estimates ranging from $5.79 (bear case) to $5.79 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $1435, with bear/bull scenarios of $-93/$3474.
Our quantitative valuation model calculates NMR's fair value at $1435 (base case), with a bear case of $-93 and bull case of $3474. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 34/100.
NMR trades at a forward P/E ratio of 11.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on NMR, with 0 Sell ratings and a price target of $5.79 (-35.7% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NMR analyst price targets range from $5.79 to $5.79, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5.79 consensus represents the middle ground. Our model's $-93-$3474 range provides an independent fundamental perspective.